Table 3 Multivariate analysis of the association of tumor ARTEMIN (ARTN) and TWIST1 expression with five-year relapse free (RFS) and overall survival (OS) in patients with estrogen receptor (ER) negative mammary carcinoma (ER-MC).
| Â | RFS | OS | ||
|---|---|---|---|---|
| Â | Odds ratio (95% CI) | P | Odds ratio (95% CI) | P |
ARTN-/ARTN+ | 1.157 (0.971-1.461) | 0.22 | 1.196 (0.943-1.518) | 0.14 |
TWIST1-/TWIST1+ | 1.733 (1.076-2.791) | 0.024 | 1.656 (1.026-2.674) | 0.039 |
Low ARTN-Low TWIST1/High ARTN-Low TWIST1 | 3.420 (0.542-92.950) | 0.029 | 3.676 (0.556-99.842) | 0.024 |
Low ARTN-Low TWIST1/High ARTN-High TWIST1 | 9.202 (0.517-163.761) | 0.014 | 9.268 (0.519-165.511) | 0.013 |